ClinicalTrials.Veeva

Menu

WAVE. Wearable-based COVID-19 Markers for Prediction of Clinical Trajectories

I

Insel Gruppe AG, University Hospital Bern

Status

Completed

Conditions

SARS-CoV 2
COVID
COVID 19

Treatments

Other: Equipment with smartwatch throughout hospital stay on the general ward

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim is to develop a wearable-based ICU (intensive care unit) prediction algorithm for inpatients contracted with SARS-CoV-2. Inpatients with suspicion of COVID-19 or with confirmed SARS-CoV-2 infection will be included. The participants will be equipped with a smartwatch, which gathers physiological data throughout hospitalisation.

Full description

The SARS-CoV-2 pandemic puts an unprecedented burden on the healthcare system, specifically its healthcare providers and the resource demands for intensive care units (ICUs). To support effective care despite large case numbers, hospital operations urgently need improved decision support in early identification of patients at risk of an acute COVID-19 deterioration that requires ICU.

The investigators aim at developing a wearable-based ICU algorithm for inpatients contracted with SARS-CoV-2. Inpatients on the general ward with suspicion of COVID-19 or with confirmed SARS-CoV-2 infection will be included. The participant will be equipped with a smartwatch and wear the device throughout the hospital stay until the patient (1) is discharged home, (2) is transferred to the ICU, or (3) palliative care is initiated. The smartwatch collects several physiological parameters (e.g. heart rate, heart rate variability, respiration rate, oxygen saturation). The collected data will be used to develop an ICU prediction algorithm to detect patients at risk of an acute COVID-19 deterioration that requires ICU.

Enrollment

46 patients

Sex

All

Ages

18 to 120 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Informed consent as documented by signature
  • Age >= 18 years
  • Suspicion of COVID-19 or patient tested positive for SARS-CoV-2
  • Hospitalisation on the general ward

Exclusion criteria

  • Smartwatch cannot be attached around the wrist of the patient
  • Direct transfer from the emergency department or external institution to ICU (i.e. no hospitalization on the general ward)
  • Known allergies to components of the smartwatch
  • Rejection of ICU transfer in the patient decree

Trial design

46 participants in 1 patient group

Smartwatch group
Treatment:
Other: Equipment with smartwatch throughout hospital stay on the general ward

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems